C.ANIRUDH JAGANNADH et al. 2013. ALEGLITAZAR – AN UPCOMING DUAL PPAR ALPHA/GAMMA AGONIST REDUCING THE MACRO VASCULAR RISKS ASSOCIATED WITH TYPE 2 DIABETES MELLITUS. International Journal of Pharma and Bio Sciences. 4, 2 (Jun. 2013), 750–754.